Western Standard has significantly reduced its stake in Alphatec Holdings (ATEC), selling 1,232,881 shares for approximately $17.95 million, according to an SEC filing on May 5, 2026. This sale reflects a $26.17 million decline in the value of its remaining holdings, which now constitute just 0.13% of Western Standard’s U.S. equity assets. The timing of this divestment coincides with Alphatec’s disappointing first-quarter earnings report, where revenue of $192 million fell short of expectations, leading to a sharp 20% drop in share price during after-hours trading.
Alphatec’s recent performance underscores the volatility surrounding its stock, despite improvements in surgical revenue and case volumes. Investors had anticipated stronger results, and the company’s lowered full-year outlook has heightened concerns. While Alphatec continues to focus on surgeon-driven innovation and expanding its product portfolio, the gap between execution and market expectations creates uncertainty.
For market professionals, the key takeaway is that while Alphatec’s long-term growth narrative remains intact, the recent performance and Western Standard’s sell-off signal caution. Investors should monitor how Alphatec addresses execution challenges in future quarters to gauge stock stability.
Source: fool.com